Danaher posts Q3 beat after broad-based growth (NYSE:DHR)
seekingalpha.com
finance
2022-10-20 11:00:50

Zerbor Danaher Corporation (NYSE:DHR) added ~3% pre-market Thursday after the life sciences company reported better-than-expected financials for Q3 2022 that its management attributed to the outperformance of all three segments. Washington, DC-based Danaher (DHR) operates three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. 'Our growth was broad-based across all three segments, a testament to the durability and attractive end-market positioning of the franchises that comprise Danaher,' Chief Executive Rainer Blair noted ahead of the earnings call at 8:00 a.
